PFM
IDXX icon

Potomac Fund Management’s Idexx Laboratories IDXX Stock Holding History

Potomac Fund Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Sell
456
-54
-11% -$30.3K 0.01% 104
2026
Q1 		$287K Sell
510
-7
-1% -$4.49K 0.01% 96
2025
Q4 		$350K Buy
517
+113
+28% +$77K 0.01% 92
2025
Q3 		$258K Buy
+404
New +$245K 0.01% 96

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Potomac Fund Management's IDXX Position: Q2 2026 in Review

Potomac Fund Management reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $30.3K and leaving 456 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #104.

Potomac Fund Management first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $350K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Potomac Fund Management held 456 shares of Idexx Laboratories worth $240K as of Q2 2026.
  • Potomac Fund Management sold 54 Idexx Laboratories shares in Q2 2026, an estimated $30.3K.
  • Idexx Laboratories made up 0.01% of Potomac Fund Management's portfolio in Q2 2026, its #104 holding.
  • Potomac Fund Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Potomac Fund Management's Idexx Laboratories position peaked at $350K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Potomac Fund Management's 13F filing for Q2 2026, filed 13 Aug 2026.